EBRD and partners acquire Egypt’s Adwia Pharmaceuticals
The FINANCIAL — The European Bank for Reconstruction and Development (EBRD) is joining forces with reputable partners to improve the availability and affordability of medicines, using an investment platform with an initial capital commitment of US$ 250 million. The EBRD is committing US$ 75 million to support the company’s growth in Egypt, alongside Development Partners International (DPI), a pan-African private equity

Latest comments